HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Naunheim, K. S. Articles by Baue, A. E. Search for Related Content PubMed PubMed Citation Articles by Naunheim, K. S. Articles by Baue, A. E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 887-893, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Preoperative chemotherapy and radiotherapy for esophageal carcinoma

KS Naunheim, P Petruska, TS Roy, CH Andrus, FE Johnson, JM Schlueter and AE Baue
Department of Surgery, St. Louis University Medical Center, Mo. 63110- 0250.

From October 1986 to January 1991, 47 patients with esophageal cancer (29 squamous, 18 adenocarcinoma) were treated with simultaneous radiotherapy (3000 or 3600 cGy) and chemotherapy (infusional 5- fluorouracil, cisplatin) delivered during a 5-week period. This treatment was well tolerated; 44 patients (94%) completed a full course of therapy, 40 (85%) had relief from dysphagia, and 21 (45%) noted either weight gain or no net weight loss. One patient (2%) died of complications (tracheoesophageal fistula, perforated ulcer) during chemotherapy and radiotherapy. The remaining 46 patients were referred for operation. Six refused because of excellent relief of their dysphagia, and one was denied operation. Thirty-nine patients went to operation, and 34 (83%) had lesions that were resectable. Eight of the 39 surgically treated patients (21%) had no evidence of residual tumor identified in the resected specimens. One of these complete responders died 7 weeks postoperatively after multiple complications (3% operative mortality rate). Three of the remaining seven have also died since the operation, one of recurrent cancer and two with no known recurrent disease. Actuarial survival in this present series was significantly better than that of our 1980 to 1985 historical control patients (p less than 0.005). There was no difference between patients with squamous carcinoma and those with adenocarcinoma with regard to the prevalence of complete response or long-term survival. Survival of the seven patients who did not undergo operation was comparable with that of the 34 patients in whom esophagectomy was performed. This study suggests that combined preoperative chemotherapy plus radiotherapy for esophageal cancer is well tolerated, provides excellent palliation of symptoms, allows for a high rate of resectability, is equally effective for squamous carcinoma and adenocarcinoma, and provides encouraging early results with regard to long-term survival. The data also call into question the role of esophagectomy, particularly in patients who have a complete response to preoperative therapy.

This article has been cited by other articles:

				H.-S. Lee, J. M. Lee, M. S. Kim, H. Y. Kim, B. Hwangbo, and J. I. Zo Low-Dose Steroid Therapy at an Early Phase of Postoperative Acute Respiratory Distress Syndrome Ann. Thorac. Surg., February 1, 2005; 79(2): 405 - 410. [Abstract] [Full Text] [PDF]

				C. E. Avendano, P. A. Flume, G. A. Silvestri, L. B. King, and C. E. Reed Pulmonary complications after esophagectomy Ann. Thorac. Surg., March 1, 2002; 73(3): 922 - 926. [Abstract] [Full Text] [PDF]

				Y. Nishimura, H. Osugi, K. Inoue, N. Takada, M. Takamura, and H. Kinosita Bronchoscopic Ultrasonography in the Diagnosis of Tracheobronchial Invasion of Esophageal Cancer J. Ultrasound Med., January 1, 2002; 21(1): 49 - 58. [Abstract] [Full Text] [PDF]

				D. R. Jones, F. C. Detterbeck, T. M. Egan, L. A. Parker Jr, S. A. Bernard, and J. E. Tepper Induction Chemoradiotherapy Followed by Esophagectomy in Patients With Carcinoma of the Esophagus Ann. Thorac. Surg., July 1, 1997; 64(1): 185 - 192. [Abstract] [Full Text]

				N. K. Altorki and D. B. Skinner OCCULT CERVICAL NODAL METASTASIS IN ESOPHAGEAL CANCER: PRELIMINARY RESULTS OF THREE-FIELD LYMPHADENECTOMY J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 540 - 544. [Abstract] [Full Text]

				K. S. Naunheim, P. J. Petruska, T. S. Roy, J. M. Schlueter, H. Kim, and A. E. Baue Multimodality Therapy for Adenocarcinoma of the Esophagus Ann. Thorac. Surg., May 1, 1995; 59(5): 1085 - 1090. [Abstract] [Full Text]